Idexx Laboratories | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 40.03B 468M 2024-12
Align Technology USD 3.85B 92.37M 2024-12
Dentsply International USD 1.94B 549M 2024-12
Dexcom USD 2.1B 123.6M 2024-12
Edwards Lifesciences USD 10B 452.8M 2024-12
Fujifilm JPY 3.39T 235.71B 2024-12
Globus Medical USD 4.18B 107.94M 2024-12
Henry Schein USD 3.39B 110M 2024-12
Hologic USD 4.77B 356.7M 2024-12
Idexx Laboratories USD 1.6B 22.74M 2024-12
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
Intuitive Surgical USD 16.53B 946.3M 2024-12
Masimo USD 1.05B 411.3M 2024-12
Neogen USD 2.66B 8.72M 2025-02
Patterson Companies USD 989.56M 26.55M 2025-01
ResMed USD 5.25B 57.98M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Steris USD 6.43B 164.94M 2024-12
Tandem Diabetes Care USD 263.1M 25.39M 2024-12
Teleflex USD 4.28B 203.58M 2024-12
Thermo Fisher Scientific USD 49.58B 592M 2024-12
Zoetis USD 4.77B 464M 2024-12



Idexx Laboratories Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.